Skip to main content
Table of Contents
Print

How are breathing problems tracked in progressive myopathies? 

Author: Harry Whitmore, Medical Student | Reviewed by: Dr. Stefan Petrov, MBBS

Progressive myopathies often lead to a gradual weakening of the muscles used for breathing, which requires consistent clinical monitoring to ensure patient safety. Because the diaphragm and intercostal muscles are responsible for expanding the lungs, any reduction in their strength can impact oxygen levels and the ability to clear the airways. Tracking these changes early allows healthcare providers to introduce supportive measures that can significantly improve quality of life and long-term health outcomes. In the United Kingdom, this monitoring is a standard part of neuromuscular care, involving a range of non-invasive tests conducted by specialist teams. Understanding how these tests work can help patients and families feel more prepared for their regular clinical reviews. Progressive myopathies involve a group of conditions where muscle fibres do not function correctly, eventually leading to weakness. When this weakness involves the muscles of the chest wall and the diaphragm, it can affect the volume of air the lungs can take in. Because these changes are often slow and subtle, they may not be noticed in daily life until the weakness is advanced. Regular tracking ensures that the respiratory system is supported before complications like chest infections or significant breathlessness occur. 

What We’ll Discuss in This Article 

  • Why respiratory muscles are specifically affected in progressive myopathies. 
  • The use of spirometry to measure lung capacity in different positions. 
  • How sleep studies identify early signs of nocturnal breathing changes. 
  • The clinical importance of measuring peak cough flow for airway safety. 
  • Identifying the physical symptoms and “red flags” of respiratory weakness. 
  • The role of the specialist respiratory multi-disciplinary team in long term care. 

The Impact of Myopathy on Respiratory Muscles 

Breathing problems are tracked because progressive myopathies weaken the primary muscles responsible for ventilation, such as the diaphragm. The NHS states that muscular dystrophy and related myopathies can cause the muscles used for breathing to become weaker over time, leading to an increased risk of chest infections. This weakness often begins in the muscles that help you take a deep breath and those that help you cough effectively. 

The diaphragm is the most important muscle for breathing, acting as a pump that draws air into the lungs. In many myopathies, the diaphragm may become weaker than the other muscles in the body. This is particularly noticeable when a person lies flat, as the abdominal organs push up against the weakened diaphragm, making it even harder to breathe. This is why clinical tracking often includes assessments in multiple physical positions. 

By monitoring the strength of these muscles, clinicians can predict when a patient might need extra help, such as with a machine to assist their breathing at night. This proactive approach is designed to prevent the lungs from becoming under-inflated, which can lead to a collapse of small air sacs and a higher risk of pneumonia. Early tracking is the most effective way to manage these risks and maintain respiratory health for as long as possible. 

Lung Function Tests and Spirometry 

Clinical teams use spirometry to track the volume of air a person can breathe out, providing a clear indication of respiratory muscle strength. The most common measurement taken is the Forced Vital Capacity, which is the maximum amount of air you can exhale after taking the deepest breath possible. This test is a reliable way to see how well the respiratory muscles are working to expand and contract the chest. 

In patients with progressive myopathy, these measurements are often taken while the patient is sitting up and then repeated while they are lying flat on their back. A significant drop in the volume of air between sitting and lying, usually more than twenty percent, is a key clinical indicator that the diaphragm is significantly weakened. This specific test is vital because a person may have a relatively normal result while sitting up even if their diaphragm is struggling. 

Spirometry is usually performed at every specialist clinic visit, often every six to twelve months. The results are plotted on a graph over time to look for any downward trends. If the values fall below a certain percentage of what is expected for the person’s age and height, the clinical team will discuss introducing supportive therapies. This objective data helps take the guesswork out of managing respiratory health. 

Sleep Studies and Nocturnal Monitoring 

Sleep studies are used to track breathing patterns overnight, as respiratory weakness often manifests first during the deeper stages of sleep. When you sleep, your breathing naturally becomes shallower, and the muscles of the chest wall relax. If the respiratory muscles are already weak due to myopathy, this can lead to nocturnal hypoventilation, where the body does not take in enough oxygen or clear enough carbon dioxide. 

Monitoring usually begins with a simple overnight pulse oximetry test, which involves wearing a small sensor on the finger to track oxygen levels while you sleep at home. If this shows any “dips” in oxygen, a more detailed study called a polysomnography or a respiratory sleep study may be required. This more advanced test monitors heart rate, chest movement, and sometimes carbon dioxide levels using a small sensor near the nose. 

These studies are essential because a person may breathe perfectly well while awake but have significantly low oxygen levels while asleep. If nocturnal hypoventilation is detected, the respiratory team may recommend non-invasive ventilation, which involves wearing a mask at night connected to a small machine that helps the lungs expand. This support often leads to better sleep quality and reduced daytime fatigue. 

Measuring Cough Strength and Airway Clearance 

Peak cough flow is tracked to assess how effectively a person can clear their airways of mucus and secretions. A strong, effective cough is the body’s primary defence against chest infections and choking. In progressive myopathies, the muscles used to “blast” air out during a cough often weaken before the muscles used to breathe in, making this a critical metric to monitor. 

To measure this, the patient is asked to take a deep breath and cough as hard as they can into a small device called a peak flow meter. The resulting number gives the clinical team an idea of how much “power” is behind the cough. If the peak cough flow falls below specific safety thresholds, it suggests that the person may struggle to clear their lungs if they develop a common cold or a chest infection. 

When cough strength is low, the respiratory physiotherapist will teach techniques to help, such as “breath stacking” or the use of manual assisted coughing. In some cases, a cough assist machine may be prescribed. This device helps by blowing air into the lungs and then quickly sucking it back out, mimicking the action of a strong natural cough. Tracking cough flow ensures these life-saving tools are provided before a respiratory crisis occurs. 

Recognising Clinical Symptoms of Breathing Weakness 

Healthcare providers track breathing by monitoring for specific symptoms such as morning headaches, daytime sleepiness, and shortness of breath when lying flat. These symptoms are often the first signs that a person is not breathing deeply enough overnight. Morning headaches are particularly telling, as they are often caused by a build-up of carbon dioxide in the blood during the night. 

Other signs that the clinical team will look for include: 

  • A quiet or “weak” sounding voice. 
  • Needing to use more pillows to prop yourself up at night. 
  • Frequent or long-lasting chest infections. 
  • Feeling unrefreshed or confused upon waking. 
  • Difficulty concentrating during the day. 

Patients are often asked to complete a symptom questionnaire during their clinic visits. This subjective information is just as important as the objective lung function tests, as it tells the team how the muscle weakness is affecting the person’s daily life. Being honest about these symptoms ensures that the right support is put in place. If these signs are ignored, the respiratory system can become overworked, leading to significant exhaustion and a decline in overall health. 

The Role of the Respiratory Multi-Disciplinary Team 

NICE clinical guidelines recommend that people with neuromuscular conditions have access to a specialist respiratory team to monitor and manage their breathing health. This multi-disciplinary team is composed of several specialists who work together to provide a comprehensive care plan. The team typically includes a consultant respiratory physician, a specialist physiotherapist, and often a specialist nurse or a technician who manages ventilation equipment. 

The respiratory physiotherapist plays a central role in tracking. They are usually the ones who perform the lung function tests and cough flow measurements. They also provide training on how to use equipment and how to perform exercises that keep the chest wall as flexible as possible. This hands-on support is vital for helping patients feel confident in managing their condition at home. 

Regular follow up with this team ensures that the patient’s respiratory care plan is updated in line with their physical needs. Because myopathies are often progressive, the support needed today may be different from the support needed in a year’s time. This collaborative approach ensures a seamless transition between monitoring and active treatment, keeping the patient’s safety and comfort at the centre of all clinical decisions. 

Conclusion 

Breathing problems in progressive myopathies are tracked through a combination of regular lung function tests, cough strength assessments, and overnight sleep studies. These clinical tools allow specialist teams to detect muscle weakness early and introduce supportive therapies like non-invasive ventilation or cough assist machines. Consistent monitoring is the most effective way to prevent respiratory complications and maintain a high quality of life. By staying engaged with a specialist multi-disciplinary team, patients can ensure their respiratory health is managed with the highest level of expertise. 

If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

How often should my breathing be tested?

Most people with progressive myopathy should have their lung function and cough strength checked every six to twelve months, or more frequently if symptoms change.

Is spirometry difficult to perform?

The test requires a deep breath and a hard blow, which can be tiring, but the respiratory physiotherapist will guide you through it at your own pace.

Why is my cough strength so important?

A strong cough prevents mucus from building up in the lungs, which is the primary way to avoid serious chest infections like pneumonia.

Will I definitely need a breathing machine?

Not everyone with myopathy will need respiratory support; it depends entirely on the type of myopathy and which specific muscles are affected. 

Can I do anything to keep my respiratory muscles strong?

Gentle respiratory exercises and using your equipment as prescribed are the best ways to support your breathing, but you should always follow your physiotherapist’s specific advice.

What should I do if I start having morning headaches?

You should contact your neuromuscular or respiratory team, as this can be a sign that your breathing is shallow during the night.

Is a sleep study uncomfortable?

Most initial sleep studies involve a simple finger sensor which is not painful, though more detailed studies may involve more sensors on the chest and face.

Authority Snapshot (E-E-A-T Block) 

This guide was developed by the Medical Content Team and reviewed by Dr. Stefan Petrov, a UK-trained physician with extensive experience in general medicine and emergency care. The information provided aligns with NHS and NICE standards for the monitoring of respiratory health in patients with neuromuscular disorders. Our goal is to provide accurate, safe, and factual public health information to help patients understand their clinical care pathways in the United Kingdom. 

Harry Whitmore, Medical Student
Author
Dr. Stefan Petrov, MBBS
Reviewer

Dr. Stefan Petrov is a UK-trained physician with an MBBS and postgraduate certifications including Basic Life Support (BLS), Advanced Cardiac Life Support (ACLS), and the UK Medical Licensing Assessment (PLAB 1 & 2). He has hands-on experience in general medicine, surgery, anaesthesia, ophthalmology, and emergency care. Dr. Petrov has worked in both hospital wards and intensive care units, performing diagnostic and therapeutic procedures, and has contributed to medical education by creating patient-focused health content and teaching clinical skills to junior doctors.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy. 

Categories